PROVIDER PROFILE · NPI 1912171075
Lara ParaskosMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,378
Unique beneficiaries
—
Total services
23,071
Distinct HCPCS
14
Medicare payment
$642K
Peer benchmark
Total Medicare services vs. 415 Endocrinology providers in FL — top quintile (cohort median 962).
PRESCRIBING · PART D · 2024
Total Rx claims
1,886
Beneficiaries
—
Total drug cost
$970K
Distinct drugs
25
Brand share
63.1%
Top prescribed drugs
Levothyroxine Sodium310 claims
Tirzepatide224 claims
Semaglutide181 claims
Levothyroxine Sodium174 claims
Metformin Hcl128 claims
QUALITY · MIPS · 2024
Final MIPS score
92.6
Quality
86.6
Cost
74.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.74%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$4K
Payment records
184
By payment type
Food and Beverage$4K
Top paying entities
Food and Beverage$4K
REFERRAL NETWORK
Where Lara Paraskos's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Clinical Laboratory · Tampa, FL | 23 | 47 |
| Abbe Rosenbaum Cardiology · South Miami, FL | 11 | 32 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE